Alpha Teknova (NASDAQ:TKNO) raised its 2026 revenue guidance after reporting a second consecutive quarter of record revenue, ...
<?xml encoding="utf-8" ?> Maravai LifeSciences MRVI reported third-quarter financial results on Wednesday. The transcript ...
<?xml encoding="utf-8" ?> Alpha Teknova TKNO reported third-quarter financial results on Wednesday. The transcript from the ...
Jaenisch, Muraru, and Pandey discuss how regulators will audit pharma against its own AI policies and ways QA and regulatory ...
New medicine applications that were used to legally prescribe medical cannabis are no longer being approved by the South ...
Need a bit of help with NYT Strands today? No shame in that, and you've come to the right place. Below, we've compiled some useful hints for Strands #977 as well as the answers, should it come to that ...
Fluor sets delivery milestones and open-book cost reporting; phased completions are expected to begin in late 2027 and run through Q2 2028.
Teknova also reaffirmed full-year free cash outflow below $8 million and completed a $46 million public stock offering in ...
The fundraising via mainboards amounted to above Rs 1 lakh crore for the third consecutive year as per PRIME Database in 2026 ...
รายได้ไตรมาส 3 ปี 2026 ของ Teknova เพิ่มขึ้น 22% หลังกลุ่ม Clinical Solutions พุ่งขึ้น 86% ...
Teknova의 2026년 3분기 매출은 Clinical Solutions 부문이 86% 급증한 데 힘입어 22% 증가했다. 회사는 2026년 매출 가이던스를 4,600만~4,800만 달러로 상향 조정했다.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results